Factors associated with the number of lesions excised for each skin cancer: A study of primary care physicians in Queensland, Australia

Archives of Dermatology

Volumn 144, Issue 11, 2008, Pages 1468-1476

  Baade, Peter D ^a,b   Youl, Philippa H ^a   Janda, Monika ^b   Whiteman, David C ^c   Del Mar, Christopher B ^d   Aitken, Joanne F ^a,e  

^a VIERTEL CENTRE FOR RESEARCH IN CANCER CONTROL   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^d BOND UNIVERSITY   (Australia)

^e UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUSTRALIA; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SKIN BIOPSY; SKIN CANCER; SKIN DEFECT; SKIN EXAMINATION;

ADULT; AGE DISTRIBUTION; ATTITUDE OF HEALTH PERSONNEL; BIOPSY, NEEDLE; CARCINOMA, BASAL CELL; CONFIDENCE INTERVALS; DERMATOLOGY; FEMALE; HEALTH CARE SURVEYS; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; QUALITY OF HEALTH CARE; QUEENSLAND; REFERRAL AND CONSULTATION; RISK ASSESSMENT; SEX DISTRIBUTION; SKIN NEOPLASMS; YOUNG ADULT;

EID: 56549115591     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archderm.144.11.1468     Document Type: Article

References (35)

1. Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol. 2002;146(suppl 61):1-6.
2. Trakatelli M, Ulrich C, del Marmol V, Euvrard S, Stockfleth E, Abeni D. Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: accurate and comparable data are needed for effective public health monitoring and interventions [published correction appears in Br J Dermatol. 2007 Sep;157(3):634]. Br J Dermatol. 2007;156(suppl 3):1-7.
3. Staples MP, Elwood M, Burton RC, Williams JL, Marks R, Giles GG. Nonmelanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust. 2006;184(1):6-10.
4. Coory M, Baade PD, Aitken JF, Smithers M, McLeod GRC, Ring I. Trends for insitu and invasive melanoma in Queensland, Australia, 1982 to 2002. Cancer Causes Control. 2006;17(1):21-27.
5. Markovic SN, Erickson LA, Rao RD, et al. Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc. 2007;82(3):364-380.
6. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, eds. Cancer Incidence in Five Continents: Volume VIII. Lyon, France: International Agency for Research on Cancer (WHO) and International Association of Cancer Registries; 2002. IARC Scientific Publication 155.
7. Australian Institute of Health and Welfare, Australasian Association of Cancer Registries. Cancer in Australia 2001. Canberra: Australian Institute of Health and Welfare; 2004. AIHW catalogue No. CAN 23.
8. Marks R, Jolley D, McCormack C, Dorevitch AP. Who removes pigmented skin lesions? a study of the ratio of melanoma to other benign pigmented tumors removed by different categories of physicians in Australia in 1989 and 1994. J Am Acad Dermatol. 1997;36(5, pt 1):721-726.
9. Resnik DB. To test or not to test: a clinical dilemma. Theor Med. 1995;16(2):141-152.
10. Norman G. Building on experience: the development of clinical reasoning. N Engl J Med. 2006;355(21):2251-2252.
11. Carli P, Nardini P, Crocetti E, De Giorgi V, Giannotti B. Frequency and characteristics of melanomas missed at a pigmented lesion clinic: a registry-based study. Melanoma Res. 2004;14(5):403-407.
12. Morton CA, Mackie RM. Clinical accuracy of the diagnosis of cutaneous malignant melanoma. Br J Dermatol. 1998;138(2):283-287.
13. Del Mar CB, Green A. Aid to diagnosis of melanoma in primary medical care. BMJ. 1995;310(6978):492-495.
14. English DR, Del Mar CB, Burton RC. Factors influencing the number needed to excise: excision rates of pigmented lesions by general practitioners. Med J Aust. 2004;180(1):16-19.
15. Australian Institute of Health and Welfare. Health System Expenditures on Cancer and Other Neoplasms in Australia, 2000-01. Canberra: Australian Institute of Health and Welfare; 2005. AIHW catalogue No. HWE 29.
16. Chen SC, Pennie ML, Kolm P, et al. Diagnosing and managing cutaneous pigmented lesions: primary care physicians versus dermatologists. J Gen Intern Med. 2006;21(7):678-682.
17. Chen JG, Fleischer AB Jr, Smith ED, et al. Cost of nonmelanoma skin cancer treatment in the United States. Dermatol Surg. 2001;27(12):1035-1038.
18. Tsao H, Rogers GS, Sober AJ. An estimate of the annual direct cost of treating cutaneous melanoma. J Am Acad Dermatol. 1998;38(5, pt 1):669-680.
19. Stang A, Stausberg J, Boedeker W, Kerek-Bodden H, Jockel KH. Nationwide hospitalization costs of skin melanoma and non-melanoma skin cancer in Germany. J Eur Acad Dermatol Venereol. 2008;22(1):65-72.
20. Medicare Australia. Medicare Benefits Schedule (MBS) Item Statistics Reports. https://www.medicareaustralia.gov.au/statistics/mbs_item.shtml. Accessed August 16, 2008.
21. Wilkinson D, Askew DA, Dixon A. Skin cancer clinics in Australia: workload profile and performance indicators from an analysis of billing data. Med J Aust. 2006;184(4):162-164.
22. FitzGerald KL, Buttner PG, Donovan SA. Nonpigmented skin lesions: how many are nonmelanoma skin cancer? Aust Fam Physician. 2006;35(7):555-557.
23. Youl PH, Baade P, Janda M, Whiteman DC, Del Mar CB, Aitken JF. Diagnosing skin cancer in primary care: how do mainstream GPs compare with primary care skin cancer clinic doctors? Med J Aust. 2007;187(4):215-220.
24. Del Mar CB, Balanda KP. Examination of skin naevi in Australian general practice: dissonance between care and need? Aust N Z J Public Health. 1998;22(3)(suppl):397-399.
25. Fahey T, Newton J. Conveying the benefits and risks of treatment. Br J Gen Pract. 1995;45(396):339-341.
26. Kricker A, English DR, Randell PL, et al. Skin cancer in Geraldton, Western Australia: a survey of incidence and prevalence. Med J Aust. 1990;152(8):399-407.
27. Youl PH, Raasch BA, Janda M, Aitken JF. The effect of an educational programme to improve the skills of general practitioners in diagnosing melanocytic/pigmented lesions. Clin Exp Dermatol. 2007;32(4):365-370.
28. Rampen FH, Casparie-van Velsen IJ, van Huystee BE, Kiemeney LA, Schouten LJ. False-negative findings in skin cancer and melanoma screening. J Am Acad Dermatol. 1995;33(1):59-63.
29. Richard MA, Grob JJ, Avril MF, et al. Delays in diagnosis and melanoma prognosis (II): the role of doctors. Int J Cancer. 2000;89(3):280-285.
30. Del Mar C, Green A, Cooney T, Cutbrush K, Lawrie S, Adkins G. Melanocytic lesions excised from the skin: what percentage are malignant? Aust J Public Health. 1994;18(2):221-223.
31. English DR, Burton RC, del Mar CB, Donovan RJ, Ireland PD, Emery G. Evaluation of aid to diagnosis of pigmented skin lesions in general practice: controlled trial randomised by practice. BMJ. 2003;327(7411):375.
32. Sellheyer K, Bergfeld WF. A retrospective biopsy study of the clinical diagnostic accuracy of common skin diseases by different specialties compared with dermatology. J Am Acad Dermatol. 2005;52(5):823-830.
33. Westbrook RH, Goyal N, Gawkrodger DJ. Diagnostic accuracy for skin cancer: comparison of general practitioner with dermatologist and dermatopathologist. J Dermatolog Treat. 2006;17(1):57-58.
34. Burton RC, Howe C, Adamson L, Reid A, Hersey P, Watson A. General practitioner screening for melanoma: sensitivity, specificity, and effect of training. J Med Screen. 1998;5(3):156-161.
35. Fletcher RH, Fletcher SW, Wagner EH. Treatment. In: Clinical Epidemiology, the Essentials. Baltimore, MD: Williams & Wilkins; 1996:129-156.